+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Synthetic Biology Market - Global Forecast 2026-2032- Product Image
Synthetic Biology Market - Global Forecast 2026-2032- Product Image
Sale

Synthetic Biology Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5533152
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Synthetic Biology Market is projected to reach USD 19.38 Billion in 2026. It is expected to continue growing at a CAGR of 9.73%, reaching USD 33.89 Billion by 2032.

Synthetic biology is moving from a research-driven discipline into an industrial platform for healthcare, agriculture, chemicals, materials, food systems, and environmental applications. Advances in DNA synthesis, genome editing, high-throughput screening, automation, and cloud-enabled biofoundries are enabling organizations to design biological systems with greater speed, precision, and reproducibility.

The sector is supported by measurable technology progress. The U.S. National Human Genome Research Institute has documented a steep decline in genome sequencing costs from approximately USD 100 million per genome in 2001 to near the USD 1,000 level in recent years. This cost compression, combined with CRISPR-based editing, mRNA platforms, and AI-assisted biological design, is expanding the commercial feasibility of engineered cells, enzymes, microbes, biosensors, and nucleic acid-based products.

Transformative Shifts in the Synthetic Biology Landscape

The synthetic biology landscape is being reshaped by the convergence of biology, engineering, computation, and advanced manufacturing. Biofoundries are standardizing the design-build-test-learn cycle, while automated liquid handling, omics analytics, next-generation sequencing, and laboratory robotics are improving throughput and data quality.

Commercial demand is shifting from isolated proof-of-concept projects toward scalable platforms. Pharmaceutical developers are using synthetic biology for cell and gene therapies, mRNA technologies, biologics optimization, and programmable medicines. Industrial biotechnology is deploying engineered microbes to produce specialty chemicals, enzymes, biomaterials, and alternative proteins, while agricultural applications focus on biological inputs, nitrogen-use efficiency, crop resilience, and reduced dependence on synthetic chemical inputs.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a core accelerator for synthetic biology by improving protein design, pathway engineering, strain optimization, biological data interpretation, and experimental planning. AI models help reduce the number of wet-lab iterations required to identify viable genetic constructs, enzymes, metabolic pathways, and therapeutic candidates.

The impact is cumulative because each experimental cycle generates structured biological data that can improve future model performance. AI-enabled protein structure prediction, generative sequence design, automated literature mining, and robotic experimentation are strengthening the connection between computational prediction and biological validation, supporting faster product development in therapeutics, enzymes, diagnostics, bio-based chemicals, sustainable materials, and precision agriculture.

Key Regional Insights: Global Synthetic Biology Demand

Asia-Pacific is becoming a high-activity synthetic biology region as China, India, Japan, South Korea, Singapore, and Australia expand genomics, biomanufacturing, and bioeconomy programs. China has invested heavily in sequencing, cell therapy research, industrial biotechnology, and biomanufacturing infrastructure, while India is building biotechnology capacity through government-backed bioeconomy initiatives, vaccine production, biosimilars, and agricultural biotechnology. Japan, South Korea, Singapore, and Australia contribute strong capabilities in precision medicine, fermentation, advanced materials, biofoundry infrastructure, and industrial biotechnology.

North America remains a global leader, driven by the United States and Canada. The United States benefits from deep venture capital, NIH and NSF-funded research, advanced therapy regulatory pathways, academic translation, and federal bioeconomy policy support, while Canada contributes strengths in genomics, vaccines, precision medicine, and sustainable biomanufacturing. Europe is anchored by the European Union, Germany, France, the United Kingdom, Italy, and Spain, with strong academic translation, industrial biotechnology clusters, and sustainability-oriented regulation. Latin America, led by Brazil and Mexico, is advancing bio-based agriculture, biofuels, and industrial fermentation, while the Middle East is increasing biotechnology investment through food security, healthcare modernization, and GCC-led diversification strategies. Africa is emerging through genomics initiatives, infectious disease surveillance, agricultural biotechnology, and capacity-building programs that support local bioeconomy development.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN is gaining relevance as Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines invest in biomedical research, precision health, food technology, and bio-based manufacturing. Singapore is the region's strongest synthetic biology hub due to coordinated research infrastructure, advanced biomanufacturing capability, supportive public funding, and a strong pharmaceutical and life sciences ecosystem, while Thailand and Malaysia are strengthening bioeconomy programs linked to agriculture, fermentation, and renewable biological feedstocks.

The GCC is using biotechnology to support economic diversification, healthcare security, and food resilience, with Saudi Arabia, the United Arab Emirates, and Qatar funding life sciences ecosystems, genomics programs, and controlled-environment agriculture. The European Union emphasizes safe, sustainable, and regulated biotechnology through research funding, biosafety governance, circular bioeconomy priorities, and programs such as Horizon Europe. BRICS economies bring scale in population health, agriculture, manufacturing, and feedstock availability, while G7 countries dominate advanced R&D, regulatory capacity, intellectual property development, and commercialization pathways. NATO members are also increasing attention to biosecurity, supply-chain resilience, dual-use governance, and the protection of critical biotechnology infrastructure.

Key Country Insights: Leading Synthetic Biology Markets

The United States leads synthetic biology commercialization through venture funding, advanced therapeutics, cloud labs, genome engineering, and biofoundry infrastructure, while Canada contributes strengths in genomics, vaccines, precision medicine, and sustainable bioprocessing. Mexico is building opportunity in biomanufacturing, medical devices, and agricultural biotechnology, and Brazil has a strong position in biofuels, sugarcane-based biotechnology, tropical agriculture, and bio-based industrial inputs.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine world-class research with industrial biotechnology demand, advanced manufacturing, clinical translation, and sustainability-driven policy support, while Russia maintains capabilities in life sciences, agriculture, vaccine research, and biosecurity-related research. China is scaling genomics, cell therapy, fermentation, and biomanufacturing; India is expanding vaccines, biosimilars, diagnostics, and bio-based agriculture; Japan and South Korea are strong in precision medicine, biologics, automation, and industrial fermentation; and Australia is advancing synthetic biology for health, agriculture, mining, environmental resilience, and biosecurity preparedness.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize platform strategies rather than single-asset development. Organizations that integrate AI design tools, automation, high-quality biological datasets, laboratory information systems, and scalable fermentation or cell-processing capacity are better positioned to reduce development timelines, improve reproducibility, and strengthen technology transfer.

Executives should also strengthen regulatory engagement, biosafety systems, biosecurity controls, and intellectual property strategy early in the development cycle. Partnerships with universities, public biofoundries, contract development and manufacturing organizations, and cloud-lab providers can accelerate validation. Leaders should map feedstock availability, supply-chain risks, energy requirements, workforce capabilities, and regional incentives before scaling commercial biomanufacturing assets.

Research Methodology

This executive summary is based on secondary research from public scientific, regulatory, and institutional sources, including government bioeconomy strategies, genome sequencing cost data, regulatory approvals, peer-reviewed biotechnology literature, patent and policy publications, clinical and agricultural biotechnology updates, and publicly available industry disclosures. The analysis emphasizes verifiable trends across synthetic biology, genome engineering, AI-enabled discovery, biomanufacturing, biosecurity, and regional innovation systems.

Insights were synthesized using a triangulation approach that compares technology adoption, policy direction, funding priorities, regulatory developments, scientific publication trends, infrastructure maturity, and commercial use cases. Geographic analysis considers research infrastructure, manufacturing capability, healthcare demand, agricultural priorities, feedstock access, workforce readiness, and biosecurity governance to identify practical opportunities and constraints across major markets.

Conclusion: Strategic Outlook

Synthetic biology is becoming a foundational technology for the next phase of biotechnology-led growth. Its value lies in the ability to engineer biological systems for targeted outcomes, from advanced therapies, diagnostics, vaccines, and biologics to sustainable chemicals, food ingredients, agricultural inputs, biosensors, and climate-relevant materials.

The strongest opportunities will emerge where AI, automation, regulatory readiness, biosafety governance, and scalable biomanufacturing converge. Organizations that invest in trusted data, responsible innovation, resilient supply chains, and regional partnerships will be best positioned to capture long-term value in the global synthetic biology market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Synthetic Biology Market, by Product Type
7.1. Introduction
7.2. Enzymes
7.2.1. DNA Modifying Enzymes
7.2.1.1. Restriction Enzymes
7.2.1.2. Polymerases
7.2.1.3. Ligases
7.2.2. RNA Modifying Enzymes
7.2.2.1. Reverse Transcriptases
7.2.2.2. RNA Polymerases
7.2.3. Protein Engineering Enzymes
7.2.3.1. Proteases
7.2.3.2. Chaperones
7.3. Oligonucleotides
7.4. Genetic Material
7.5. Kits & Reagents
7.5.1. Cloning Kits
7.5.2. PCR Kits
7.5.3. Genome Editing Kits
7.6. Software
7.6.1. Design Software
7.6.2. Simulation Software
7.6.3. Analysis Software
7.7. Services
7.7.1. Gene Synthesis Services
7.7.2. DNA Assembly Services
7.7.3. Protein Expression Services
8. Synthetic Biology Market, by Technology
8.1. Introduction
8.2. Genome Editing
8.2.1. CRISPR Cas Systems
8.2.2. TALENs
8.3. DNA Synthesis
8.3.1. Chemical Synthesis
8.3.2. Enzymatic Synthesis
8.4. Gene Assembly
8.5. Metabolic Engineering
8.6. Synthetic Genomics
8.7. Cell Free Systems
9. Synthetic Biology Market, by Molecule Type
9.1. Introduction
9.2. DNA Based Systems
9.3. RNA Based Systems
9.4. Protein Based Systems
9.5. Metabolic Pathway Systems
10. Synthetic Biology Market, by Application
10.1. Introduction
10.2. Agriculture
10.2.1. Genetically Modified Crops
10.2.2. Synthetic Fertilizers
10.3. Environmental
10.3.1. Bioremediation
10.3.2. Carbon Capture
10.3.3. Waste Treatment
10.4. Industrial
10.4.1. Biocatalysts
10.4.2. Biofuels
10.4.3. Bioplastics & Biopolymers
10.4.4. Specialty Chemicals
10.5. Life Sciences
10.5.1. Drug Discovery
10.5.2. Gene Therapy
10.5.3. Personalized Medicine
10.5.4. Vaccine Development
11. Synthetic Biology Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Agriculture & Food Companies
11.4. Contract Research Organizations
11.5. Pharmaceutical & Biotechnology Companies
12. Synthetic Biology Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Synthetic Biology Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Synthetic Biology Market, by Country
14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. Australia
14.8. France
14.9. South Korea
14.10. Italy
14.11. Canada
14.12. Russia
14.13. Brazil
14.14. Mexico
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Agilent Technologies, Inc.
16.2. Amyris, Inc.
16.3. Arzeda
16.4. Batavia Biosciences B.V.
16.5. Beam Therapeutics
16.6. BGI Genomics Co., Ltd.
16.7. Codexis, Inc.
16.8. Conagen, Inc.
16.9. Creative Enzymes
16.10. Danaher Corporation
16.11. DNA TwoPointO Inc.
16.12. Editas Medicine, Inc.
16.13. Eurofins Scientific SE
16.14. GenScript Biotech Corporation
16.15. Ginkgo Bioworks, Inc.
16.16. Illumina, Inc.
16.17. Merck KGaA
16.18. New England Biolabs GmbH
16.19. Novozymes A/S
16.20. Precigen, Inc.
16.21. QIAGEN N.V.
16.22. Sangamo Therapeutics
16.23. Scarab Genomics, LLC
16.24. Synlogic
16.25. Synthego Corporation
16.26. TeselaGen Service
16.27. Thermo Fisher Scientific Inc.
16.28. Twist Bioscience Corporation
List of Figures
FIGURE 1. GLOBAL SYNTHETIC BIOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL SYNTHETIC BIOLOGY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL SYNTHETIC BIOLOGY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL SYNTHETIC BIOLOGY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL SYNTHETIC BIOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL SYNTHETIC BIOLOGY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL SYNTHETIC BIOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL DNA MODIFYING ENZYMES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL DNA MODIFYING ENZYMES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL DNA MODIFYING ENZYMES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL RESTRICTION ENZYMES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL RESTRICTION ENZYMES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL RESTRICTION ENZYMES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL POLYMERASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL POLYMERASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL POLYMERASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL LIGASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL LIGASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL LIGASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL RNA MODIFYING ENZYMES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL RNA MODIFYING ENZYMES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL RNA MODIFYING ENZYMES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL REVERSE TRANSCRIPTASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL REVERSE TRANSCRIPTASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL REVERSE TRANSCRIPTASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL RNA POLYMERASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL RNA POLYMERASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL RNA POLYMERASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL PROTEIN ENGINEERING ENZYMES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL PROTEIN ENGINEERING ENZYMES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL PROTEIN ENGINEERING ENZYMES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL PROTEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL PROTEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL PROTEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL CHAPERONES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL CHAPERONES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL CHAPERONES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL OLIGONUCLEOTIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL OLIGONUCLEOTIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL GENETIC MATERIAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL GENETIC MATERIAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL GENETIC MATERIAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL KITS & REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL KITS & REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL KITS & REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CLONING KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CLONING KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL CLONING KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL PCR KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL PCR KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL PCR KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL GENOME EDITING KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL GENOME EDITING KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL GENOME EDITING KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL DESIGN SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL DESIGN SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL DESIGN SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL SIMULATION SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL SIMULATION SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL SIMULATION SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ANALYSIS SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ANALYSIS SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL GENE SYNTHESIS SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL GENE SYNTHESIS SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL GENE SYNTHESIS SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL DNA ASSEMBLY SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL DNA ASSEMBLY SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL DNA ASSEMBLY SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL PROTEIN EXPRESSION SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL PROTEIN EXPRESSION SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL PROTEIN EXPRESSION SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL GENOME EDITING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL GENOME EDITING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL GENOME EDITING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL CRISPR CAS SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL CRISPR CAS SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL CRISPR CAS SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL TALENS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL TALENS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL TALENS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL DNA SYNTHESIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL DNA SYNTHESIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL CHEMICAL SYNTHESIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL CHEMICAL SYNTHESIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL CHEMICAL SYNTHESIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL ENZYMATIC SYNTHESIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL ENZYMATIC SYNTHESIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL ENZYMATIC SYNTHESIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL GENE ASSEMBLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL GENE ASSEMBLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL GENE ASSEMBLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL METABOLIC ENGINEERING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL METABOLIC ENGINEERING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL METABOLIC ENGINEERING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL SYNTHETIC GENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL SYNTHETIC GENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL SYNTHETIC GENOMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL CELL FREE SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL CELL FREE SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL CELL FREE SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL DNA BASED SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL DNA BASED SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL DNA BASED SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL RNA BASED SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL RNA BASED SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL RNA BASED SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL PROTEIN BASED SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL PROTEIN BASED SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL PROTEIN BASED SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL METABOLIC PATHWAY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL METABOLIC PATHWAY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL METABOLIC PATHWAY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL AGRICULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL AGRICULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL AGRICULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL GENETICALLY MODIFIED CROPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL GENETICALLY MODIFIED CROPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL GENETICALLY MODIFIED CROPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL SYNTHETIC FERTILIZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL SYNTHETIC FERTILIZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL SYNTHETIC FERTILIZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL ENVIRONMENTAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL ENVIRONMENTAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL ENVIRONMENTAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL BIOREMEDIATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL BIOREMEDIATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL BIOREMEDIATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL CARBON CAPTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL CARBON CAPTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL CARBON CAPTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL WASTE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL WASTE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL WASTE TREATMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL INDUSTRIAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL INDUSTRIAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL INDUSTRIAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL BIOCATALYSTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL BIOCATALYSTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL BIOCATALYSTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL BIOFUELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL BIOFUELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL BIOFUELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL BIOPLASTICS & BIOPOLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL BIOPLASTICS & BIOPOLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL BIOPLASTICS & BIOPOLYMERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL SPECIALTY CHEMICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL SPECIALTY CHEMICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL SPECIALTY CHEMICALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL LIFE SCIENCES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 161. GLOBAL LIFE SCIENCES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL LIFE SCIENCES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 164. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 165. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 166. GLOBAL GENE THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 167. GLOBAL GENE THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL GENE THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 169. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 170. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 171. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 172. GLOBAL VACCINE DEVELOPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 173. GLOBAL VACCINE DEVELOPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 174. GLOBAL VACCINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 175. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 176. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 177. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 178. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 179. GLOBAL AGRICULTURE & FOOD COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 180. GLOBAL AGRICULTURE & FOOD COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 181. GLOBAL AGRICULTURE & FOOD COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 182. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 183. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 184. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 185. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 186. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 187. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 188. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2017-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2017-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2017-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2017-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, 2017-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL, 2017-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL, 2017-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY LIFE SCIENCES, 2017-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 208. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 209. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 210. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 211. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 212. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 213. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2017-2032 (USD MILLION)
TABLE 214. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2017-2032 (USD MILLION)
TABLE 215. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 216. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 217. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 218. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2017-2032 (USD MILLION)
TABLE 219. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2017-2032 (USD MILLION)
TABLE 220. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 221. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 222. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, 2017-2032 (USD MILLION)
TABLE 223. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL, 2017-2032 (USD MILLION)
TABLE 224. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL, 2017-2032 (USD MILLION)
TABLE 225. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY LIFE SCIENCES, 2017-2032 (USD MILLION)
TABLE 226. EUROPE SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 227. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 228. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 229. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 230. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 231. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 232. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2017-2032 (USD MILLION)
TABLE 233. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2017-2032 (USD MILLION)
TABLE 234. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 235. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 236. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 237. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2017-2032 (USD MILLION)
TABLE 238. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2017-2032 (USD MILLION)
TABLE 239. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 240. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 241. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, 2017-2032 (USD MILLION)
TABLE 242. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL, 2017-2032 (USD MILLION)
TABLE 243. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL, 2017-2032 (USD MILLION)
TABLE 244. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY LIFE SCIENCES, 2017-2032 (USD MILLION)
TABLE 245. NORTH AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 246. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 247. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 248. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 249. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 250. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 251. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2017-2032 (USD MILLION)
TABLE 252. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2017-2032 (USD MILLION)
TABLE 253. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 254. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 255. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 256. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2017-2032 (USD MILLION)
TABLE 257. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2017-2032 (USD MILLION)
TABLE 258. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 259. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 260. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, 2017-2032 (USD MILLION)
TABLE 261. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL, 2017-2032 (USD MILLION)
TABLE 262. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL, 2017-2032 (USD MILLION)
TABLE 263. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY LIFE SCIENCES, 2017-2032 (USD MILLION)
TABLE 264. LATIN AMERICA SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 265. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 266. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 267. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 268. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 269. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 270. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2017-2032 (USD MILLION)
TABLE 271. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2017-2032 (USD MILLION)
TABLE 272. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 273. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 274. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 275. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2017-2032 (USD MILLION)
TABLE 276. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2017-2032 (USD MILLION)
TABLE 277. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 278. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 279. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, 2017-2032 (USD MILLION)
TABLE 280. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL, 2017-2032 (USD MILLION)
TABLE 281. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL, 2017-2032 (USD MILLION)
TABLE 282. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY LIFE SCIENCES, 2017-2032 (USD MILLION)
TABLE 283. AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 284. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 285. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 286. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 287. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 288. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 289. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2017-2032 (USD MILLION)
TABLE 290. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2017-2032 (USD MILLION)
TABLE 291. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 292. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 293. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 294. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2017-2032 (USD MILLION)
TABLE 295. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2017-2032 (USD MILLION)
TABLE 296. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 297. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 298. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, 2017-2032 (USD MILLION)
TABLE 299. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL, 2017-2032 (USD MILLION)
TABLE 300. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL, 2017-2032 (USD MILLION)
TABLE 301. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY LIFE SCIENCES, 2017-2032 (USD MILLION)
TABLE 302. MIDDLE EAST SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 303. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 304. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 305. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 306. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 307. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 308. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 309. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2017-2032 (USD MILLION)
TABLE 310. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2017-2032 (USD MILLION)
TABLE 311. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 312. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 313. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 314. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2017-2032 (USD MILLION)
TABLE 315. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2017-2032 (USD MILLION)
TABLE 316. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 317. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 318. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, 2017-2032 (USD MILLION)
TABLE 319. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL, 2017-2032 (USD MILLION)
TABLE 320. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL, 2017-2032 (USD MILLION)
TABLE 321. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY LIFE SCIENCES, 2017-2032 (USD MILLION)
TABLE 322. NATO SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 323. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 324. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 325. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 326. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 327. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 328. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2017-2032 (USD MILLION)
TABLE 329. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2017-2032 (USD MILLION)
TABLE 330. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 331. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 332. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 333. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2017-2032 (USD MILLION)
TABLE 334. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2017-2032 (USD MILLION)
TABLE 335. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 336. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 337. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, 2017-2032 (USD MILLION)
TABLE 338. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL, 2017-2032 (USD MILLION)
TABLE 339. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL, 2017-2032 (USD MILLION)
TABLE 340. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY LIFE SCIENCES, 2017-2032 (USD MILLION)
TABLE 341. G7 SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 342. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 343. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 344. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 345. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 346. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 347. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2017-2032 (USD MILLION)
TABLE 348. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2017-2032 (USD MILLION)
TABLE 349. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 350. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 351. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 352. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2017-2032 (USD MILLION)
TABLE 353. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY DNA SYNTHESIS, 2017-2032 (USD MILLION)
TABLE 354. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 355. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 356. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, 2017-2032 (USD MILLION)
TABLE 357. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL, 2017-2032 (USD MILLION)
TABLE 358. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL, 2017-2032 (USD MILLION)
TABLE 359. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY LIFE SCIENCES, 2017-2032 (USD MILLION)
TABLE 360. BRICS SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 361. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 362. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 363. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 364. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY DNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 365. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY RNA MODIFYING ENZYMES, 2017-2032 (USD MILLION)
TABLE 366. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN ENGINEERING ENZYMES, 2017-2032 (USD MILLION)
TABLE 367. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY KITS & REAGENTS, 2017-2032 (USD MILLION)
TABLE 368. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 369. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 370. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 371. EUROPEAN UNION SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME EDITING, 2017-2032 (USD MILLION)
TABLE 372. EUROPEAN UNION SYNTHETIC BIOLOGY

Companies Mentioned

  • Agilent Technologies, Inc.
  • Amyris, Inc.
  • Arzeda
  • Batavia Biosciences B.V.
  • Beam Therapeutics
  • BGI Genomics Co., Ltd.
  • Codexis, Inc.
  • Conagen, Inc.
  • Creative Enzymes
  • Danaher Corporation
  • DNA TwoPointO Inc.
  • Editas Medicine, Inc.
  • Eurofins Scientific SE
  • GenScript Biotech Corporation
  • Ginkgo Bioworks, Inc.
  • Illumina, Inc.
  • Merck KGaA
  • New England Biolabs GmbH
  • Novozymes A/S
  • Precigen, Inc.
  • QIAGEN N.V.
  • Sangamo Therapeutics
  • Scarab Genomics, LLC
  • Synlogic
  • Synthego Corporation
  • TeselaGen Service
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 19.38 Billion
Forecasted Market Value ( USD ) by 2032 $ 33.89 Billion
Compound Annual Growth Rate9.7%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Synthetic Biology for Food Market - Global Forecast 2026-2032 - Product Image

Synthetic Biology for Food Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Agriculture Synthetic Biology Market - Global Forecast 2026-2032 - Product Image

Agriculture Synthetic Biology Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
The Global Synthetic Biology & Biomanufacturing Market 2026-2036 - Product Image

The Global Synthetic Biology & Biomanufacturing Market 2026-2036

  • Report
  • 1135 Pages
  • Global
Synthetic Biology Market Size, Share, Trends and Forecast by Product, Technology, Application, and Region, 2026-2034 - Product Image

Synthetic Biology Market Size, Share, Trends and Forecast by Product, Technology, Application, and Region, 2026-2034

  • Report
  • 142 Pages
  • Global
From
Synthetic Biology Market Size, Share & Trends Analysis Report by Product, Technology, Application, End Use, Region, and Segment Forecasts, 2026-2033 - Product Image

Synthetic Biology Market Size, Share & Trends Analysis Report by Product, Technology, Application, End Use, Region, and Segment Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.